彩运网

NKF sincerely invites global customers to gather at CPHI Europe to explore new opportunities for cooperation together!

Create a trustworthy pharmaceutical future together!

2025-10-21

Learn more +
NKF attended the 25th anniversary celebration of GMS in Pakistan to deepen strategic cooperation

It has laid a solid foundation for future market expansion.

2025-10-17

Learn more +
NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing

Continue to effectively leverage the advantages of the high-standard quality system and the integrated platform

2025-08-04

Learn more +
NKF makes its debut at CPHI Southeast Asia

It has opened up new channels for the company to penetrate the Southeast Asian and even the global market

2025-07-21

Learn more +
King-Friend will meet you in CPHI Malaysia！

Explore the infinite possibilities of the pharmaceutical industry!

2025-07-14

Learn more +
NKF's subsidiary Kindos's Hydralazine Hydrochloride Injection gets FDA approval for marketing

Strengthen and expand the international base of high-quality injectables

2025-06-09

Learn more +
NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing

Continue to promote high-quality products and services to a new level

2025-05-26

Learn more +
NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing

Another quick approval

2025-05-22

Learn more +
Paclitaxel For Injection (Albumin Bound) approved by US FDA

2025-05-20

Learn more +

1
2
3

Stock price

9.400

-0.06

?2025 Nanjing King-Friend Biochemical Pharmaceutical Co.Ltd苏ICP备13012010号

【网站地图】【sitemap】